Showing results 1 to 4 of 4
Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation Kim, Min Hwan; Kim, Jongshin; Hong, Hyowon; Lee, Si-Hyung; Lee, June Koo; Jung, Eunji; Kim, Joon, EMBO JOURNAL, v.35, no.5, pp.462 - 478, 2016-03 |
BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts Kemper, Kristel; Krijgsman, Oscar; Kong, Xiangjun; Cornelissen-Steijger, Paulien; Shahrabi, Aida; Weeber, Fleur; van der Velden, Daphne L.; et al, CELL REPORTS, v.16, no.1, pp.263 - 277, 2016-06 |
Immune checkpoint inhibitors for cancer treatment Park, Junsik; Kwon, Minsuk; Shin, Eui-Cheol, ARCHIVES OF PHARMACAL RESEARCH, v.39, no.11, pp.1577 - 1587, 2016-11 |
YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma Kim, Min Hwan; Kim, Chang Gon; Kim, Sang-Kyum; Shin, Sang Joon; Choe, Eun Ah; Park, Su-Hyung; Shin, Eui-Cheol; et al, CANCER IMMUNOLOGY RESEARCH, v.6, no.3, pp.255 - 266, 2018-03 |
Discover